Tagged privo

Press Release

Privo Technologies, Inc. Announces Positive Results From Phase 1/2 Clinical Trial for PRV111 in Head and Neck Squamous Cell Carcinoma

 Read More
Privo Technologies, Inc. Awarded $3M NIDCR NIH Commercialization Readiness Pilot Grant
Press Release

Privo Technologies, Inc. Awarded $3M NIDCR NIH Commercialization Readiness Pilot Grant

 Read More
Privo Technologies Named Winner of AIM-HI Accelerator Fund's Inaugural Women's Venture Competition
Press Release

Privo Technologies Named Winner of AIM-HI Accelerator Fund's Inaugural Women's Venture Competition

 Read More
Privo Technologies, Inc. to Present Phase II Data for PRV111 in Head and Neck Squamous Cell Carcinoma at the Upcoming 2021 ASCO Annual Meeting
Press Release

Privo Technologies, Inc. to Present Phase II Data for PRV111 in Head and Neck Squamous Cell Carcinoma at the Upcoming 2021 ASCO Annual Meeting

 Read More
Press Release

Privo Achieves End User Computing (EUC) Competency Status​

 Read More